These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9234351)

  • 1. Procedure for red blood cell labelling with 99mTc-HMPAO. Methodology and quality control.
    Bassa P; García Garzón JR; Piera C; Pavía A; Minoves M; Moragas M; Pavía J; Lomeña F; Setoain J
    Nucl Med Biol; 1994 Oct; 21(7):963-7. PubMed ID: 9234351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labelling of leukocytes with 99mTc-HMPAO for scintigraphy of inflammatory lesions and abscesses.
    Vanlić-Razumenić N; Pujić N; Dedović N; Kostić K; Nastić-Mirić D
    Int J Rad Appl Instrum B; 1992 Apr; 19(3):251-6. PubMed ID: 1629013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO.
    Welling M; Feitsma HI; Blok D; Calame W; Ensing GJ; Goedemans W; Pauwels EK
    Q J Nucl Med; 1995 Jun; 39(2):89-98. PubMed ID: 8574810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple procedure for red blood cell labeling with Tc-99m HMPAO. Preliminary clinical results.
    Vorne M; Laitinen R
    Clin Nucl Med; 1992 Jan; 17(1):14-7. PubMed ID: 1311998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.
    Ecclestone M; Proulx A; Ballinger JR; Gerson B; Reid RH; Gulenchyn KY
    Eur J Nucl Med; 1990; 16(4-6):299-302. PubMed ID: 2161770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
    Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
    Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilisation of high-activity 99mTc-d,l-HMPAO preparations with cobalt chloride and their biological behaviour.
    Mang'era KO; Vanbilloen HP; Schiepers CW; Verbruggen AM
    Eur J Nucl Med; 1995 Oct; 22(10):1163-72. PubMed ID: 8542901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabelling of human platelets with 99mTc-HMPAO.
    Vorne M; Honkanen T; Karppinen K; Röning M; Sakki S
    Eur J Haematol; 1989 May; 42(5):487-91. PubMed ID: 2731595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tc-99m-HMPAO labelled human platelets: in vitro and in vivo results.
    Becker W; Borst U; Krahe T; Börner W
    Eur J Nucl Med; 1989; 15(6):296-301. PubMed ID: 2767079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.
    Capriotti G; D'Alessandria C; Garin E; Weber E; Devillers A; Lehmann K; Corsetti F; Lecloirec J; Meller J; Becker W; Moisan A; Signore A
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):229-36. PubMed ID: 15499297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of 99Tcm-HMPAO and 99Tcm-ECD as a leukocyte labelling agent.
    Kao CH; Huang WT; Wang YL; Lin KS; Lo JM; Wang SJ
    Nucl Med Commun; 1994 Apr; 15(4):294-7. PubMed ID: 8072744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents.
    Tsai CS; Kao CH; Yeh SJ; Wang SJ
    Nucl Med Commun; 1996 Jan; 17(1):76-9. PubMed ID: 8692477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of overall inflammatory bowel disease activity using labelled leucocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods.
    Mansfield JC; Giaffer MH; Tindale WB; Holdsworth CD
    Gut; 1995 Nov; 37(5):679-83. PubMed ID: 8549945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high-efficiency, rapid and multi-dose procedure for white blood cell labelling with 99Tcm-HMPAO.
    Ozker K; Collier BD; Hellman RS; Isitman AT; Krasnow AZ; Uzum F; Steffel FS
    Nucl Med Commun; 1996 Apr; 17(4):342-5. PubMed ID: 8786871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-pool imaging using technetium-99m-labeled liposomes.
    Goins B; Phillips WT; Klipper R
    J Nucl Med; 1996 Aug; 37(8):1374-9. PubMed ID: 8708778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m and indium-111 double labelling of granulocytes for kinetic and clinical studies.
    Aktolun C; Ussov WY; Arka A; Glass D; Gunasekera RD; Peters AM
    Eur J Nucl Med; 1995 Apr; 22(4):330-4. PubMed ID: 7607263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of the secretion of technetium-99m hexamethylpropylene amine oxime into breast milk.
    Marshall DS; Newberry NR; Ryan PJ
    Eur J Nucl Med; 1996 Dec; 23(12):1634-5. PubMed ID: 8929318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease.
    Giaffer MH; Tindale WB; Holdsworth D
    Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1195-200. PubMed ID: 8980940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte labeling with 99mTc-HMPAO. The role of the in vitro stability of HMPAO on the labeling efficacy and image quality.
    Papós M; Láng J; Rajtár M; Csernay L
    Nucl Med Biol; 1994 Aug; 21(6):893-5. PubMed ID: 9234340
    [No Abstract]   [Full Text] [Related]  

  • 20. The behavior of 99mTc-hexamethylpropyleneamineoxime (99mTc-HMPAO) in blood and brain.
    Nakamura K; Tukatani Y; Kubo A; Hashimoto S; Terayama Y; Amano T; Goto F
    Eur J Nucl Med; 1989; 15(2):100-7. PubMed ID: 2920737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.